MBRX - Moleculin's WP1122 confirms antiviral potential against coronavirus July, 21 2020 08:54 AM Moleculin Biotech Inc. Moleculin Biotech (NASDAQ:MBRX) rises ~35% PM in reaction to independent laboratory testing that confirms antiviral activity of WP1122 against coronavirus.More news on: Moleculin Biotech, Inc., Healthcare stocks news, Stocks on the move, Read more ...